Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 3/20 | 0.42 |
| ▸ | HTR2C | P28335 | 1/20 | 0.40 |
| ▸ | HTR2B | P41595 | 1/20 | 0.40 |
| ▸ | REN | P00797 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.40 |
| ▸ | UBE2N | P61088 | 1/20 | 0.40 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.40 |
| ▸ | F2 | P00734 | 1/20 | 0.39 |
| ▸ | F10 | P00742 | 1/20 | 0.39 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.39 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.39 |
| ▸ | F7 | P08709 | 1/20 | 0.39 |
| ▸ | F3 | P13726 | 1/20 | 0.39 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | APP | P05067 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31161171 | 1.00 | SLC6A4 (0.42) | SLC6A4HTR2CHTR2BRENPOLB | |
| SCHEMBL13117260 | 0.86 | PTPN1 (0.37) | HTR2CHTR2B | |
| SCHEMBL31161165 | 0.83 | HIF1A (0.38) | SLC6A4RENPOLBKMT2AC5AR1 | |
| SCHEMBL13117273 | 0.82 | LMNA (0.51) | KMT2AHSD17B10GAARAB9ALMNA | |
| SCHEMBL16553284 | 0.81 | FAAH (0.44) | KMT2AAPPMEN1GAAKDM4E | |
| SCHEMBL16553285 | 0.81 | FAAH (0.44) | KMT2AAPPMEN1GAAKDM4E | |
| SCHEMBL17135859 | 0.81 | FAAH (0.44) | KMT2AAPPMEN1GAAKDM4E | |
| SCHEMBL17135858 | 0.81 | FAAH (0.44) | KMT2AAPPMEN1GAAKDM4E | |
| SCHEMBL16553283 | 0.81 | FAAH (0.44) | KMT2AAPPMEN1GAAKDM4E | |
| SCHEMBL17135857 | 0.81 | FAAH (0.44) | KMT2AAPPMEN1GAAKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4698522-A1 | METHODS FOR PREPARING (-)-EPICATECHIN | Mars, Incorporated (US) | 2026-02-25 | — | — | EP | disclosed |
| US-20260042741-A1 | METHODS FOR PREPARING (-)-EPICATECHIN | MARS, INCORPORATED (US) | 2026-02-12 | — | — | US | disclosed |
| WO-2024220193-A1 | METHODS FOR PREPARING (-)-EPICATECHIN | MARS, INCORPORATED (US) | 2024-10-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260042741-A1 | METHODS FOR PREPARING (-)-EPICATECHIN | CYP2E1, CYP1A1, ADH1A | SLC6A4 3809/4885HTR2C 1533/4885HTR2B 2268/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.